Cargando…

Detection of microsatellite instability with Idylla MSI assay in colorectal and endometrial cancer

Universal testing of microsatellite instability (MSI) is recommended for colorectal cancer (CRC) and endometrial cancer (EC) to screen for Lynch syndrome and to aid in assessing prognosis and optimal treatment. We compared the performance of Idylla MSI test to immunohistochemistry (IHC) of mismatch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ukkola, Iiris, Nummela, Pirjo, Pasanen, Annukka, Kero, Mia, Lepistö, Anna, Kytölä, Soili, Bützow, Ralf, Ristimäki, Ari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448708/ https://www.ncbi.nlm.nih.gov/pubmed/33755781 http://dx.doi.org/10.1007/s00428-021-03082-w

Ejemplares similares

Diagnostic performance of Idylla MSI test in colorectal cancer biopsies
por: Ukkola, Iiris, et al.
Publicado: (2023)

N-Glycomic Profiling of Microsatellite Unstable Colorectal Cancer
por: Ukkola, Iiris, et al.
Publicado: (2023)

Gene fusions and oncogenic mutations in MLH1 deficient and BRAFV600E wild-type colorectal cancers
por: Ukkola, Iiris, et al.
Publicado: (2022)

Frequency of microsatellite instability (MSI) in upper tract urothelial carcinoma: comparison of the Bethesda panel and the Idylla MSI assay in a consecutively collected, multi-institutional cohort
por: Kullmann, Friederike, et al.
Publicado: (2023)

Detection of KRAS mutations in liquid biopsies from metastatic colorectal cancer patients using droplet digital PCR, Idylla, and next generation sequencing
por: Holm, Matilda, et al.
Publicado: (2020)

Clinicopathologic vs. Molecular Integrated Prognostication of Endometrial Carcinoma by European Guidelines
por: Loukovaara, Mikko, et al.
Publicado: (2022)

Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Molecularly Classified Endometrial Carcinoma
por: Loukovaara, Mikko, et al.
Publicado: (2021)

Mismatch repair protein and MLH1 methylation status as predictors of response to adjuvant therapy in endometrial cancer
por: Loukovaara, Mikko, et al.
Publicado: (2021)

Interpretable prognostic modeling of endometrial cancer
por: Zagidullin, Bulat, et al.
Publicado: (2022)

Differential impact of clinicopathological risk factors within the 2 largest ProMisE molecular subgroups of endometrial carcinoma
por: Pasanen, Annukka, et al.
Publicado: (2021)

Clinical factors as prognostic variables among molecular subgroups of endometrial cancer
por: Kolehmainen, Anne, et al.
Publicado: (2020)

Pancytopenia And Limbic Encephalopathy Complicating Immunotherapy For Clear Cell Endometrial Cancer With Microsatellite Instability-High (MSI-H)
por: Kanbour, Aladdin, et al.
Publicado: (2019)

Multiple components of PKA and TGF-β pathways are mutated in pseudomyxoma peritonei
por: Saarinen, Lilli, et al.
Publicado: (2017)

Testing for Lynch Syndrome in Endometrial Carcinoma: From Universal to Age-Selective MLH1 Methylation Analysis
por: Pasanen, Annukka, et al.
Publicado: (2022)

Multi-center real-world comparison of the fully automated Idylla™ microsatellite instability assay with routine molecular methods and immunohistochemistry on formalin-fixed paraffin-embedded tissue of colorectal cancer
por: Velasco, Ana, et al.
Publicado: (2020)

Interaction between Microsatellite Instability (MSI) and Tumor DNA Methylation in the Pathogenesis of Colorectal Carcinoma
por: Jasmine, Farzana, et al.
Publicado: (2021)

Endometrial cancer and microsatellite instability status
por: Kanopiene, Daiva, et al.
Publicado: (2014)

Dabrafenib and trametinib activity in a patient with BRAF V600E mutated and microsatellite instability high (MSI-H) metastatic endometrial cancer
por: Moschetta, Michele, et al.
Publicado: (2017)

Development and analytical validation of a next-generation sequencing based microsatellite instability (MSI) assay
por: Pabla, Sarabjot, et al.
Publicado: (2019)

Low Expression of Stanniocalcin 1 (STC-1) Protein Is Associated With Poor Clinicopathologic Features of Endometrial Cancer
por: Khatun, Masuma, et al.
Publicado: (2021)

Altered glycosylation of glycodelin in endometrial carcinoma
por: Hautala, Laura C., et al.
Publicado: (2020)

Mutations in the WTX - gene are found in some high-grade microsatellite instable (MSI-H) colorectal cancers
por: Scheel, Silvio K, et al.
Publicado: (2010)

Advantage of HSP110 (T17) marker inclusion for microsatellite instability (MSI) detection in colorectal cancer patients
por: Berardinelli, Gustavo Noriz, et al.
Publicado: (2018)

MEM: An Algorithm for the Reliable Detection of Microsatellite Instability (MSI) on a Small NGS Panel in Colorectal Cancer
por: Herbreteau, Guillaume, et al.
Publicado: (2021)

xDEEP-MSI: Explainable Bias-Rejecting Microsatellite Instability Deep Learning System in Colorectal Cancer
por: Bustos, Aurelia, et al.
Publicado: (2021)

DeltaMSI: artificial intelligence-based modeling of microsatellite instability scoring on next-generation sequencing data
por: Swaerts, Koen, et al.
Publicado: (2023)

EMAST Type of Microsatellite Instability—A Distinct Entity or Blurred Overlap between Stable and MSI Tumors
por: Vuković Đerfi, Kristina, et al.
Publicado: (2023)

Modal variety of microsatellite instability in human endometrial carcinomas
por: Eto, Takako, et al.
Publicado: (2015)

New use of microsatellite instability analysis in endometrial cancer
por: Kunitomi, Haruko, et al.
Publicado: (2017)

MED12 mutations and fumarate hydratase inactivation in uterine adenomyomas
por: Heikkinen, Tuomas, et al.
Publicado: (2018)

A novel NGS-based microsatellite instability (MSI) status classifier with 9 loci for colorectal cancer patients
por: Zheng, Kai, et al.
Publicado: (2020)

Detection of microsatellite instability high (MSI-H) status by targeted plasma-based genotyping in metastatic breast cancer
por: Vidula, Neelima, et al.
Publicado: (2022)

N-glycomic profiling of colorectal cancer according to tumor stage and location
por: Holm, Matilda, et al.
Publicado: (2020)

Efficacy of PD-1 Inhibitor Combined with Bevacizumab in Treatment of Advanced Endometrial Cancer Patients with Mismatch Repair Deficiency (dMMR)/High-Level Microsatellite Instability (MSI-H)
por: Liao, Ying, et al.
Publicado: (2022)

High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine
por: Gatalica, Zoran, et al.
Publicado: (2016)

Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation
por: McCarthy, Aoife J, et al.
Publicado: (2018)

Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA
por: Barata, Pedro, et al.
Publicado: (2020)

Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers
por: Palmeri, M., et al.
Publicado: (2021)

Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancer
por: Chakrabarti, Sakti, et al.
Publicado: (2022)

Treatment patterns and real-world clinical outcomes in patients with advanced endometrial cancer that are non-microsatellite instability high (non-MSI-high) or mismatch repair proficient (pMMR) in the United States
por: Kelkar, Sneha S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ulbm13ufhc51q6maqf1gntltat